VARENICLINE, NALTREXONE, AND THEIR COMBINATION FOR HEAVY-DRINKING SMOKERS: PRELIMINARY NEUROIMAGING FINDINGS

RATIONALE: Heavy drinking smokers constitute a sizeable and hard-to-treat subgroup of smokers, for whom tailored smoking cessation therapies are not yet available. OBJECTIVE: The present study used a double-blind, randomized, 2×2 medication design, testing varenicline alone (VAR; 1mg twice daily), n...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Drug Alcohol Abuse
Hlavní autoři: Ray, Lara A., Courtney, Kelly E., Ghahremani, Dara G., Miotto, Karen, Brody, Arthur, London, Edythe D.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4365972/
https://ncbi.nlm.nih.gov/pubmed/24949564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/00952990.2014.927881
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky